Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients.
Alcon, the global leader in eye care and a division of Novartis, presented a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery.